UCB SA (EBR:UCB)
Belgium · Delayed Price · Currency is EUR 242.00
+1.10 (0.46%)
May 22, 2026, 5:35 PM CET
UCB SA Market Cap
UCB SA has a market cap or net worth of €46.07 billion as of May 22, 2026. Its market cap has increased by 54.74% in one year.
Market Cap
46.07B
Enterprise Value
45.95B
Revenue
7.74B
Ranking
n/a
PE Ratio
30.14
Stock Price
€242.00
Market Cap Chart
Since April 5, 1995, UCB SA's market cap has increased from 890.67M to 46.07B, an increase of 5,072.25%. That is a compound annual growth rate of 13.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 45.86B | 1.16% |
| Dec 31, 2025 | 45.33B | 24.32% |
| Dec 31, 2024 | 36.46B | 143.60% |
| Dec 29, 2023 | 14.97B | 7.12% |
| Dec 30, 2022 | 13.97B | -26.25% |
| Dec 31, 2021 | 18.95B | 18.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 43.92B |
| Financière de Tubize | 9.25B |
| Onward Medical | 195.03M |
| Hyloris Pharmaceuticals | 141.12M |
| European Medical Solutions | 22.85M |
| Celyad Oncology | 13.43M |
| BioSenic | 1.44M |
| Oxurion NV | 319.29K |